Samil Pharm (000520) — Cash Flow Quality Index
Samil Pharm (000520) has a Cash Flow Quality Index of 5.01x as of June 2024. Operating cash flow of ₩1.75 Billion exceeds net income of ₩350.31 Million, indicating high earnings quality where cash backs reported profits. Explore Samil Pharm long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Samil Pharm Cash Flow Quality Index (2013–2023)
Historical Cash Flow Quality Index for Samil Pharm across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 000520 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Samil Pharm (2013–2023)
Year-by-year earnings quality comparison for Samil Pharm. For live market cap and the full company financial profile, see 000520 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 7.06x | ₩11.75 Billion | ₩1.66 Billion | ▲ +21.7% |
| 2020 | 5.80x | ₩7.77 Billion | ₩1.34 Billion | ▼ -56.9% |
| 2019 | 13.47x | ₩10.59 Billion | ₩786.26 Million | ▲ +111.9% |
| 2016 | 6.35x | ₩5.63 Billion | ₩886.60 Million | ▲ +28.1% |
| 2015 | 4.96x | ₩2.92 Billion | ₩588.37 Million | ▲ +1086.3% |
| 2013 | -0.50x | ₩-3.99 Billion | ₩7.93 Billion | — |